TY  -  
T1  - Evolving Care and Diagnostics in Inflammatory Bowel Diseases : Infliximab Therapy Optimization & Motility-based Crohn's Disease Detection 
SN  -  /  
UR  - URN:ISBN:978-951-51-8036-0; http://hdl.handle.net/10138/342794 
T3  -  
A1  - Arkko, Anssi 
A2  -  
PB  - Helsingin yliopisto 
Y1  - 2022 
LA  - en 
AB  - This thesis presents three studies aiming to improve both medical care and diagnostics for the inflammatory bowel diseases (IBD): Crohn’s disease (CD), ulcerative colitis (UC), and unspecified IBD (IBDU). Biological drugs such as the TNF-α antagonist infliximab (IFX) have presented a major improvement in medicinal care for moderate-to-severe IBD. Not all patients benefit from a particular biological drug, however, and many eventually lose their initial response. The drugs are also costly and car... 
VO  -  
IS  -  
SP  -  
OP  -  
KW  - lääketiede 
N1  -   
PP  -  
ER  -